EM-T3Pharmacoepidemiology and Drug Safety2019-08-11第 29 卷第 7 期,811-813
Barriers and facilitators to conduct high‐quality, large‐scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience